Endometrial preparation for in vitro oocyte maturation: early use of estrogen increases endometrial tissue and requires lower daily dosage: a cross over trial in 'mock' cycles

J Assist Reprod Genet. 2006 May;23(5):241-6. doi: 10.1007/s10815-006-9042-4. Epub 2006 May 19.

Abstract

Purpose: Determine if estrogen used since the beginning of the menstrual flow could improve endometrial tissue compared to standard endometrial preparation for in vitro maturation cycles.

Methods: Twenty polycystic ovary syndrome women were submitted to two estrogen therapy schedules: standard schedule; estrogen began on the day of planned egg retrieval (dosage was based on endometrial thickness); and long schedule; estrogen began on the first day of menstruation. No oocyte retrieval or embryo transfer was performed. Three-dimensional ultrasound was performed on the day of planned egg retrieval and one week later for endometrial evaluation.

Results: A higher endometrial thickness and volume was found in long schedule on both evaluations. The number of patients that have used 10 mg/day of estradiol was significant higher in the standard schedule (65%x0%). No other significant difference was found.

Conclusions: The early use of estrogen improves endometrial tissue and requires lower daily dosage.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Arteries / diagnostic imaging
  • Cross-Over Studies
  • Dydrogesterone / therapeutic use
  • Endometrium / blood supply
  • Endometrium / diagnostic imaging
  • Endometrium / drug effects*
  • Estradiol / analogs & derivatives*
  • Estradiol / therapeutic use
  • Female
  • Humans
  • Ovarian Follicle / drug effects
  • Ovarian Follicle / physiology
  • Polycystic Ovary Syndrome / physiopathology
  • Polycystic Ovary Syndrome / therapy*
  • Sperm Injections, Intracytoplasmic
  • Ultrasonography
  • Uterus / blood supply
  • Uterus / diagnostic imaging

Substances

  • Estradiol
  • Dydrogesterone